Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Nasopharyngeal carcinoma"" wg kryterium: Temat


Tytuł :
Usefulness of F-fluorodeoxyglucose positron-emission tomography/computed tomography combined with the platelet-lymphocyte ratio in predicting the prognosis of nasopharyngeal carcinoma.
Autorzy :
Xian WJ; Department of Nuclear Medicine, The First People's Hospital of Foshan, Foshan, China.
Feng YL; Department of Nuclear Medicine, The First People's Hospital of Foshan, Foshan, China.
Wang Y; Department of Nuclear Medicine, The First People's Hospital of Foshan, Foshan, China.
Yang M; Department of Nuclear Medicine, The First People's Hospital of Foshan, Foshan, China.
Lu SN; Department of Nuclear Medicine, The First People's Hospital of Foshan, Foshan, China.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2022 Jan 01; Vol. 95 (1129), pp. 20210279. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Lymphocyte Count*
Platelet Count*
Radiopharmaceuticals*
Nasopharyngeal Carcinoma/*blood
Nasopharyngeal Carcinoma/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Chemoradiotherapy ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/mortality ; Nasopharyngeal Carcinoma/therapy ; Prognosis ; Progression-Free Survival ; Proportional Hazards Models ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma.
Autorzy :
Luo Y; Department of Otorhinolaryngology, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, China.
Qu X; Department of Pain Treatment, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, China.
Kan D; Department of Otorhinolaryngology, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, China.
Cai B; Department of Otorhinolaryngology, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 6967-6980.
Typ publikacji :
Journal Article
MeSH Terms :
Nasopharyngeal Carcinoma*/genetics
Nasopharyngeal Carcinoma*/metabolism
Nasopharyngeal Carcinoma*/pathology
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/metabolism
Nasopharyngeal Neoplasms*/pathology
Cellular Apoptosis Susceptibility Protein/*genetics
MicroRNAs/*genetics
Adult ; Animals ; Apoptosis/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Cellular Apoptosis Susceptibility Protein/metabolism ; Female ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; MicroRNAs/metabolism ; Middle Aged ; Transcriptome/genetics
Czasopismo naukowe
Tytuł :
Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma.
Autorzy :
Wu LZ; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Huang ML; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Qi CL; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Shen LJ; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Zou Y; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Yang R; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Sheng JF; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Chen SM; Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.; Research Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 3398-3409.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nasopharyngeal Carcinoma*/genetics
Nasopharyngeal Carcinoma*/metabolism
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/metabolism
Proto-Oncogene Proteins c-akt/*genetics
Radiation Tolerance/*genetics
Receptor, Notch2/*genetics
Cell Line, Tumor ; Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Receptor, Notch2/metabolism ; Signal Transduction/genetics ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Tytuł :
Human/eukaryotic ribosomal protein L14 (RPL14/eL14) overexpression represses proliferation, migration, invasion and EMT process in nasopharyngeal carcinoma.
Autorzy :
Zhang Z; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Zhang Y; Department of Ultrasonic Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Qiu Y; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Mo W; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Yang Z; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 2175-2186.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nasopharyngeal Carcinoma/*genetics
Nasopharyngeal Neoplasms/*genetics
Ribosomal Proteins/*genetics
Adult ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cadherins/genetics ; Cadherins/metabolism ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/genetics ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/pathology ; Nasopharynx/metabolism ; Nasopharynx/pathology ; Ribosomal Proteins/metabolism ; Vimentin/genetics ; Vimentin/metabolism
Czasopismo naukowe
Tytuł :
Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.
Autorzy :
Luo WJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
He SW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Zou WQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Zhao Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
He QM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Yang XJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Guo R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Mao YP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Pokaż więcej
Źródło :
Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2021 Dec; Vol. 246 (24), pp. 2618-2629. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Activin Receptors, Type I/*metabolism
Epstein-Barr Virus Infections/*virology
MicroRNAs/*metabolism
Nasopharyngeal Carcinoma/*pathology
Nasopharyngeal Neoplasms/*pathology
RNA, Viral/*metabolism
Cell Dedifferentiation/physiology ; Cell Proliferation/physiology ; Gene Expression Regulation, Neoplastic/physiology ; Herpesvirus 4, Human ; Humans ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/virology ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Socioeconomic Status and Survival in Nasopharyngeal Carcinoma: A Population-Based Study.
Autorzy :
Brody-Camp S; Department of Otorhinolaryngology, Ochsner Health System, New Orleans, Louisiana, U.S.A.
McCoul ED; Department of Otorhinolaryngology, Ochsner Health System, New Orleans, Louisiana, U.S.A.; Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana, U.S.A.
Lefante JJ; Department of Global Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, U.S.A.
Aslam R; Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana, U.S.A.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2021 Dec; Vol. 131 (12), pp. 2719-2723. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Social Class*
Chemoradiotherapy/*statistics & numerical data
Nasopharyngeal Carcinoma/*mortality
Nasopharyngeal Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/diagnosis ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Carcinoma/therapy ; Nasopharyngeal Neoplasms/diagnosis ; Nasopharyngeal Neoplasms/pathology ; Nasopharyngeal Neoplasms/therapy ; Neoplasm Staging ; Retrospective Studies ; SEER Program ; Survival Rate ; United States
Czasopismo naukowe
Tytuł :
Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase.
Autorzy :
Liu F; Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Wei J; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Hao Y; Cancer Center, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Lan J; Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Li W; Health Management Center, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Weng J; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Li M; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Su C; Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Li B; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Mo M; Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Tang F; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Wang Y; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Yang Y; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Jiao W; Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Qu S; Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning City, P.R. China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 7119-7130.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nasopharyngeal Carcinoma*/genetics
Nasopharyngeal Carcinoma*/metabolism
Nasopharyngeal Carcinoma*/mortality
Nasopharyngeal Carcinoma*/pathology
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/metabolism
Nasopharyngeal Neoplasms*/mortality
Nasopharyngeal Neoplasms*/pathology
MicroRNAs/*genetics
RNA, Long Noncoding/*genetics
Cell Line, Tumor ; Disease Progression ; Fatty Acid Synthase, Type I/genetics ; Fatty Acid Synthase, Type I/metabolism ; Humans ; MicroRNAs/metabolism ; Nasopharynx/pathology ; RNA, Long Noncoding/metabolism ; Sterol Regulatory Element Binding Protein 1/genetics ; Sterol Regulatory Element Binding Protein 1/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł :
Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
Autorzy :
Pan X; Department of Oncology, Xiangya Third Hospital, Central South University, Changsha, China.
Liu JH; School of Pharmaceutical Sciences of Central South University, Changsha, 410078, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 3647-3661.
Typ publikacji :
Journal Article
MeSH Terms :
Nasopharyngeal Carcinoma*/diagnosis
Nasopharyngeal Carcinoma*/genetics
Nasopharyngeal Carcinoma*/metabolism
Nasopharyngeal Neoplasms*/diagnosis
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/metabolism
Transcriptome*/drug effects
Transcriptome*/genetics
Antineoplastic Agents/*pharmacology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Gene Expression Profiling ; Gene Regulatory Networks/drug effects ; Gene Regulatory Networks/genetics ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
Autorzy :
Chen H; Department of Radiation Oncology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Wei L; Department of Endoscopy, Guangxi Medical University Affiliated Tumor Hospital, Nanning, China.
Luo M; Department of Oncology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wang X; Department of Oncology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhan Y; Department of Oncology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Mao Y; Department of Oncology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Huang C; Department of Oncology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li J; Department of Dermatology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lu H; Department of Radiation Oncology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Pokaż więcej
Źródło :
Environmental toxicology [Environ Toxicol] 2021 Nov; Vol. 36 (11), pp. 2291-2301. Date of Electronic Publication: 2021 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
DNA Damage*
Nasopharyngeal Carcinoma*/drug therapy
Nasopharyngeal Carcinoma*/radiotherapy
Nasopharyngeal Neoplasms*/drug therapy
Nasopharyngeal Neoplasms*/radiotherapy
Radiation Tolerance*
2-Naphthylamine/*analogs & derivatives
Arginine/*analogs & derivatives
Protein-Arginine Deiminase Type 4/*antagonists & inhibitors
2-Naphthylamine/pharmacology ; Apoptosis ; Arginine/pharmacology ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Humans ; Protein-Arginine Deiminases
Czasopismo naukowe
Tytuł :
Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.
Autorzy :
Liang YJ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Wen DX; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Luo MJ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Tang LQ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Guo SS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Wang P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Chen QY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Liu LT; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Mai HQ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Dec; Vol. 159, pp. 133-143. Date of Electronic Publication: 2021 Nov 04.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy/*methods
Chemotherapy, Adjuvant/*methods
Induction Chemotherapy/*methods
Nasopharyngeal Carcinoma/*therapy
Nasopharyngeal Neoplasms/*therapy
Adolescent ; Antineoplastic Agents/therapeutic use ; Child ; Child, Preschool ; DNA, Viral ; Epstein-Barr Virus Infections/complications ; Female ; Herpesvirus 4, Human ; Humans ; Male ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/virology ; Progression-Free Survival ; Radiotherapy, Intensity-Modulated/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Characterization of the nasopharynx microbiota in patients with nasopharyngeal carcinoma vs. healthy controls.
Autorzy :
Li L; Department of Radiation Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, China.
Deng X; Department of Radiation Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, China.
Zou Y; Department of Radiation Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, China.
Lv X; Department of Radiation Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, China.
Guo Y; Department of Microecology, School of Basic Medical Science, Dalian Medical University, No. 9, West Segment of South Lvshun Road, Lvshunkou District, Dalian, 116044, China. .
Pokaż więcej
Źródło :
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] [Braz J Microbiol] 2021 Dec; Vol. 52 (4), pp. 1873-1880. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji :
Journal Article
MeSH Terms :
Bacteria*/classification
Bacteria*/genetics
Biodiversity*
Nasopharyngeal Carcinoma*/microbiology
Nasopharyngeal Neoplasms*/microbiology
Nasopharynx*/microbiology
Tumor Microenvironment*
Case-Control Studies ; Humans ; RNA, Ribosomal, 16S/genetics
Czasopismo naukowe
Tytuł :
Overexpression of HOXA10 promotes the growth and metastasis of nasopharyngeal carcinoma.
Autorzy :
Gong D; Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang 330006, China.
Zhu H; Department of Breast Cancer Surgery, Jiangxi Provincial Cancer Hospital, Nanchang 330029, China.
Zeng L; Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang 330006, China.
Hu R; Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang 330006, China.
Hu J; Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang 330006, China.
Ding J; Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang 330006, China.
Pokaż więcej
Źródło :
Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2021 Dec; Vol. 246 (23), pp. 2454-2462. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinogenesis/*genetics
Homeobox A10 Proteins/*metabolism
Nasopharyngeal Carcinoma/*pathology
Nasopharyngeal Neoplasms/*pathology
Calcium-Calmodulin-Dependent Protein Kinase Kinase/genetics ; Calcium-Calmodulin-Dependent Protein Kinase Kinase/metabolism ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Homeobox A10 Proteins/genetics ; Humans ; Matrix Metalloproteinase 1/genetics ; Matrix Metalloproteinase 1/metabolism ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Neoplasms/genetics ; RNA Interference ; RNA, Small Interfering/genetics ; S-Phase Kinase-Associated Proteins/genetics ; S-Phase Kinase-Associated Proteins/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Transcriptional Activation/genetics ; Up-Regulation/genetics
Czasopismo naukowe
Tytuł :
Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
Autorzy :
Zong JF; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liang QD; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Lu QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liu YH; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Xu HC; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Chen BJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Guo QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Xu Y; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Hu CR; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Pan JJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.
Lin SJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China. .; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1274. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/mortality
Antibodies, Monoclonal, Humanized/*therapeutic use
Nasopharyngeal Carcinoma/*therapy
Nasopharyngeal Neoplasms/*therapy
Neoplasm Recurrence, Local/*therapy
Radiation-Sensitizing Agents/*therapeutic use
Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Induction Chemotherapy/methods ; Male ; Middle Aged ; Mucositis/etiology ; Nasopharyngeal Carcinoma/mortality ; Nasopharyngeal Neoplasms/mortality ; Neoplasm Recurrence, Local/mortality ; Radiation Injuries/pathology ; Radiotherapy, Intensity-Modulated/adverse effects ; Retrospective Studies ; Survival Rate ; Xerostomia/etiology
Czasopismo naukowe
Tytuł :
Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Autorzy :
Zhao DW; Medical School of Chinese PLA, No.28 Fuxing Road, Beijing, 100853, China.; Department of Radiology, Pingjin Hospital, Characteristic Medical center of Chinese People's Armed Police Force, Tianjin, China.; Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Fan WJ; Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China.; Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan, China.; Armed Police Forces Corps Hospital of Henan Province, No.1 Kangfu Road, Zhengzhou, 450052, China.
Meng LL; Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Luo YR; Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Wei J; Department of Otolaryngology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Liu K; Department of Otolaryngology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Liu G; Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Li JF; Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Zang X; Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Li M; Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhang XX; Department of Otolaryngology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Ma L; Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, China. .
Pokaż więcej
Źródło :
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2021 Nov 10; Vol. 21 (1), pp. 59. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji :
Journal Article
MeSH Terms :
Induction Chemotherapy*
Diffusion Magnetic Resonance Imaging/*methods
Magnetic Resonance Imaging/*methods
Nasopharyngeal Carcinoma/*drug therapy
Nasopharyngeal Neoplasms/*diagnostic imaging
Nasopharyngeal Neoplasms/*drug therapy
Adolescent ; Adult ; Aged ; Benchmarking ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/diagnostic imaging ; Predictive Value of Tests ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Autorzy :
Van Sciver N; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Ohashi M; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Nawandar DM; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.; Currently at Ring Therapeutics, Cambridge, Massachusetts, United States of America.
Pauly NP; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Lee D; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Makielski KR; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Bristol JA; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Tsao SW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Lambert PF; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.
Johannsen EC; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Kenney SC; Department of Oncology, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, Wisconsin, United States of America.; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Nov 08; Vol. 17 (11), pp. e1010045. Date of Electronic Publication: 2021 Nov 08 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Virus Latency*
Epstein-Barr Virus Infections/*complications
Herpesvirus 4, Human/*pathogenicity
Keratinocytes/*virology
Nasopharyngeal Carcinoma/*virology
Nasopharyngeal Neoplasms/*virology
Transcription Factors/*metabolism
Tumor Suppressor Proteins/*metabolism
Cell Differentiation ; Epithelial Cells/virology ; Epstein-Barr Virus Infections/virology ; Host-Pathogen Interactions ; Humans ; Immediate-Early Proteins/genetics ; Immediate-Early Proteins/metabolism ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/pathology ; Transcription Factors/genetics ; Tumor Suppressor Proteins/genetics ; Virus Activation
Czasopismo naukowe
Tytuł :
Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.
Autorzy :
Viswanathan K; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA; Department of Pathology, Emory University, Atlanta, GA, 30322, USA.
Sadow PM; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Electronic address: .
Pokaż więcej
Źródło :
Human pathology [Hum Pathol] 2021 Nov; Vol. 117, pp. 88-100. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*metabolism
Epstein-Barr Virus Infections/*diagnosis
Nasopharyngeal Carcinoma/*diagnosis
Nasopharyngeal Neoplasms/*diagnosis
Receptors, Somatostatin/*metabolism
Adult ; Aged ; Biomarkers, Tumor/analysis ; Epstein-Barr Virus Infections/complications ; Female ; Herpesvirus 4, Human ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/virology ; Receptors, Somatostatin/analysis ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation.
Autorzy :
Tamin S; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Adham M; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Noer A; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Supriana N; Department of Radio Oncology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Bardosono S; Department of Nutrition Science, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Dec 09; Vol. 16 (12), pp. e0261110. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy/*adverse effects
Deglutition Disorders/*pathology
Endoscopy, Digestive System/*methods
Nasopharyngeal Carcinoma/*therapy
Nasopharyngeal Neoplasms/*therapy
Respiratory Aspiration/*physiopathology
Adult ; Deglutition Disorders/etiology ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Nasopharyngeal carcinoma: an evolving paradigm.
Autorzy :
Wong KCW; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Lo KW; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Lam WKJ; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Johnson D; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Li L; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Tao Q; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Chan KCA; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
To KF; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
King AD; Department of Diagnostic Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Ma BBY; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR. .
Chan ATC; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR. .
Pokaż więcej
Źródło :
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 Nov; Vol. 18 (11), pp. 679-695. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Nasopharyngeal Carcinoma*
Humans
Czasopismo naukowe
Tytuł :
Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90.
Autorzy :
Li HM; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Ma H; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Sun X; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Li B; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Cao C; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Dai Y; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Zhu M; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Wu CZ; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Oct 30; Vol. 26 (21). Date of Electronic Publication: 2021 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Phytogenic/*pharmacology
Ginkgo biloba/*chemistry
HSP90 Heat-Shock Proteins/*antagonists & inhibitors
Nasopharyngeal Carcinoma/*drug therapy
Nasopharyngeal Neoplasms/*drug therapy
Salicylates/*pharmacology
Animals ; Antineoplastic Agents, Phytogenic/chemistry ; Antineoplastic Agents, Phytogenic/isolation & purification ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Female ; HSP90 Heat-Shock Proteins/metabolism ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/pathology ; Salicylates/chemistry ; Salicylates/isolation & purification ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Autorzy :
Zhang P; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.
Shao Y; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.
Quan F; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.
Liu L; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.
Yang J; Department of Oncology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Oct 15; Vol. 283, pp. 119840. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Glycolysis*
Radiation Tolerance*
Signal Transduction*
F-Box-WD Repeat-Containing Protein 7/*metabolism
Nasopharyngeal Carcinoma/*metabolism
Nasopharyngeal Neoplasms/*metabolism
Neoplasm Proteins/*metabolism
TOR Serine-Threonine Kinases/*metabolism
Animals ; Cell Line, Tumor ; F-Box-WD Repeat-Containing Protein 7/genetics ; Female ; Fructose-Bisphosphatase/genetics ; Fructose-Bisphosphatase/metabolism ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Middle Aged ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Carcinoma/radiotherapy ; Nasopharyngeal Neoplasms/genetics ; Nasopharyngeal Neoplasms/pathology ; Nasopharyngeal Neoplasms/radiotherapy ; Neoplasm Proteins/genetics ; TOR Serine-Threonine Kinases/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies